QRG Capital Management Inc. Boosts Stake in Oracle Corporation $ORCL

QRG Capital Management Inc. lifted its stake in shares of Oracle Corporation (NYSE:ORCL) by 12.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 300,056 shares of the enterprise software provider’s stock after buying an additional 34,397 shares during the period. QRG Capital Management Inc.’s holdings in Oracle were worth $43,973,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ORCL. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Oracle in the second quarter worth about $625,454,000. Edmond DE Rothschild Holding S.A. boosted its position in Oracle by 8.7% in the second quarter. Edmond DE Rothschild Holding S.A. now owns 79,008 shares of the enterprise software provider’s stock valued at $11,579,000 after buying an additional 6,296 shares during the last quarter. New Mexico Educational Retirement Board boosted its position in Oracle by 4.2% in the fourth quarter. New Mexico Educational Retirement Board now owns 76,590 shares of the enterprise software provider’s stock valued at $14,928,000 after buying an additional 3,100 shares during the last quarter. Valeo Financial Advisors LLC increased its holdings in Oracle by 4.6% in the 2nd quarter. Valeo Financial Advisors LLC now owns 80,686 shares of the enterprise software provider’s stock worth $11,825,000 after buying an additional 3,584 shares during the period. Finally, Elevation Point Wealth Partners LLC increased its holdings in Oracle by 37.9% in the 1st quarter. Elevation Point Wealth Partners LLC now owns 43,004 shares of the enterprise software provider’s stock worth $6,326,000 after buying an additional 11,820 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ORCL. Barclays lifted their price objective on shares of Oracle from $250.00 to $252.00 and gave the company an “overweight” rating in a research note on Friday, September 11th. Stifel Nicolaus cut their price objective on shares of Oracle from $220.00 to $200.00 and set a “buy” rating on the stock in a research note on Friday, September 11th. BTIG Research reissued a “buy” rating and set a $400.00 target price on shares of Oracle in a report on Friday, June 5th. Guggenheim restated a “buy” rating and set a $400.00 target price on shares of Oracle in a research report on Tuesday, September 8th. Finally, Jefferies Financial Group lowered their price target on shares of Oracle from $320.00 to $290.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirty have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $252.58.

Insiders Place Their Bets

In other Oracle news, CEO Michael Sicilia sold 10,882 shares of the company’s stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $139.94, for a total value of $1,522,827.08. Following the completion of the transaction, the chief executive officer owned 149,084 shares in the company, valued at approximately $20,862,814.96. This represents a 6.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company’s stock.

Oracle Stock Performance

Oracle stock traded down $4.76 during mid-day trading on Wednesday, hitting $144.44. The company had a trading volume of 22,584,953 shares, compared to its average volume of 29,321,357. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89. Oracle Corporation has a 12-month low of $114.50 and a 12-month high of $322.54. The company’s fifty day moving average is $142.15 and its 200-day moving average is $160.41. The company has a market capitalization of $436.75 billion, a price-to-earnings ratio of 22.64, a P/E/G ratio of 1.06 and a beta of 1.74.

Oracle (NYSE:ORCL) last posted its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.18. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The firm had revenue of $19.34 billion during the quarter, compared to analyst estimates of $19.13 billion. During the same period in the previous year, the firm earned $1.47 EPS. The business’s quarterly revenue was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Equities research analysts predict that Oracle Corporation will post 6.67 EPS for the current year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. Oracle’s payout ratio is presently 31.35%.

Key Stories Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle expanded its Digital Assets Data Nexus with payment-execution integrations, configurable wallet and smart-contract controls, and AI-assisted risk oversight. The enhancements could support growth in banking and digital-money workloads. Oracle Expands Digital Assets Data Nexus
• Positive Sentiment: New Oracle Health offerings—including an oncology electronic health record, AI-powered revenue-cycle management and expanded life-sciences analytics—strengthen Oracle’s position in healthcare technology and could create longer-term subscription opportunities. Oracle Oncology EHR
• Positive Sentiment: Oracle’s collaboration with the Buck Institute and its partnership with Wipro on cloud-based pharmacovigilance services broaden applications for Oracle Health and Life Sciences data platforms. Oracle and Buck Institute Collaboration
• Neutral Sentiment: Customer adoption remained visible through Co-op Live’s use of Oracle Simphony Cloud POS and NetSuite, while FlashGrid added support for Oracle AI Database 26ai. These announcements validate demand but provided no near-term financial guidance. Co-op Live Oracle Cloud Applications
• Negative Sentiment: Investors continued to focus on reports of more than 500 U.S. cloud-infrastructure layoffs, including engineers and developers. The cuts may improve efficiency, but also raise questions about execution and demand. Oracle Cloud Layoffs
• Negative Sentiment: Concerns about Project Jupiter’s data-center financing, rising borrowing costs and negative free cash flow are making the company’s AI buildout appear increasingly capital-intensive. This could limit valuation despite strong cloud demand and backlog growth. Oracle Debt and Layoff Concerns

Oracle Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.